Compare Abbott India with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AUROBINDO PHARMA ABBOTT INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 50.6 11.3 446.9% View Chart
P/BV x 15.8 1.4 1,142.6% View Chart
Dividend Yield % 1.4 0.8 187.1%  

Financials

 ABBOTT INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
AUROBINDO PHARMA
Mar-21
ABBOTT INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs18,5691,023 1,815.0%   
Low Rs13,970333 4,190.8%   
Sales per share (Unadj.) Rs2,028.2422.8 479.7%  
Earnings per share (Unadj.) Rs325.092.0 353.4%  
Cash flow per share (Unadj.) Rs352.4110.0 320.4%  
Dividends per share (Unadj.) Rs275.004.00 6,875.0%  
Avg Dividend yield %1.70.6 286.6%  
Book value per share (Unadj.) Rs1,203.7374.3 321.6%  
Shares outstanding (eoy) m21.25585.94 3.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.01.6 500.1%   
Avg P/E ratio x50.17.4 678.8%  
P/CF ratio (eoy) x46.26.2 748.7%  
Price / Book Value ratio x13.51.8 745.8%  
Dividend payout %84.64.3 1,945.4%   
Avg Mkt Cap Rs m345,717397,398 87.0%   
No. of employees `000NANA-   
Total wages/salary Rs m4,92735,350 13.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m43,100247,746 17.4%  
Other income Rs m8353,809 21.9%   
Total revenues Rs m43,935251,555 17.5%   
Gross profit Rs m9,18981,480 11.3%  
Depreciation Rs m58110,554 5.5%   
Interest Rs m183745 24.5%   
Profit before tax Rs m9,26073,990 12.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,35320,098 11.7%   
Profit after tax Rs m6,90753,892 12.8%  
Gross profit margin %21.332.9 64.8%  
Effective tax rate %25.427.2 93.5%   
Net profit margin %16.021.8 73.7%  
BALANCE SHEET DATA
Current assets Rs m35,185198,235 17.7%   
Current liabilities Rs m10,309106,652 9.7%   
Net working cap to sales %57.737.0 156.1%  
Current ratio x3.41.9 183.6%  
Inventory Days Days419 23.2%  
Debtors Days Days252 4.1%  
Net fixed assets Rs m3,041135,778 2.2%   
Share capital Rs m213586 36.3%   
"Free" reserves Rs m25,366218,713 11.6%   
Net worth Rs m25,579219,299 11.7%   
Long term debt Rs m01,684 0.0%   
Total assets Rs m38,226334,013 11.4%  
Interest coverage x51.7100.3 51.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.7 152.0%   
Return on assets %18.516.4 113.4%  
Return on equity %27.024.6 109.9%  
Return on capital %36.933.8 109.2%  
Exports to sales %0.753.8 1.3%   
Imports to sales %12.316.4 75.1%   
Exports (fob) Rs m295133,248 0.2%   
Imports (cif) Rs m5,30640,615 13.1%   
Fx inflow Rs m353133,248 0.3%   
Fx outflow Rs m5,38944,946 12.0%   
Net fx Rs m-5,03588,302 -5.7%   
CASH FLOW
From Operations Rs m7,26733,289 21.8%  
From Investments Rs m-7185,987 -12.0%  
From Financial Activity Rs m-5,818-13,648 42.6%  
Net Cashflow Rs m73125,831 2.8%  

Share Holding

Indian Promoters % 0.0 48.8 -  
Foreign collaborators % 75.0 3.1 2,442.7%  
Indian inst/Mut Fund % 7.7 38.3 20.2%  
FIIs % 0.2 20.8 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.2 51.9%  
Shareholders   90,567 338,639 26.7%  
Pledged promoter(s) holding % 0.0 14.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Tanks 750 Points as Energy, Auto Stocks Fall; Reliance, ONGC & Titan Top Losers(10:30 am)

Asian share markets erased early gains and fell in the negative territory tracking a sharp fall on Wall Street.

Related Views on News

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

How to Find the Next Multibagger Stock in the Market(Profit Hunter)

Jun 17, 2022

The #1 make or break factor in your portfolio you shouldn't ignore.

Is the Market Correction Over?(Fast Profits Daily)

Jun 17, 2022

In this video I'll show you why I think the market correction could be coming to an end.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 1, 2022 02:01 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - NATURAL CAPS COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS